Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL26088738 | 0.97 | CA5A (0.40) | — | |
| Sulfuric Acid SCHEMBL28123593 | 0.81 | CA5A (0.55) | — | |
| Sulfuric Acid SCHEMBL8579392 | 0.81 | CA5A (0.55) | — | |
| Sulfuric Acid SCHEMBL9316832 | 0.81 | CA5A (0.55) | — | |
| Sulfuric Acid SCHEMBL497410 | 0.81 | — | — | |
| Sulfuric Acid SCHEMBL28195830 | 0.77 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL27982895 | 0.77 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL27939839 | 0.77 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL22776129 | 0.77 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL11409348 | 0.77 | CA5A (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118772021-A | Amphoteric betaine compounds | 伊士曼化工公司 | 2024-10-15 | — | — | CN | claimed |
| EP-3350160-B1 | MIXTURES OF AMPHOTERIC BETAINE COMPOUNDS AND AN ENZYMIC PROCESS FOR THEIR PRODUCTION | EASTMAN CHEM CO (US) | 2021-05-26 | — | — | EP | claimed |
| EP-3350160-A1 | AMPHOTERIC BETAINE COMPOUNDS | Eastman Chemical Company (US) | 2018-07-25 | — | — | EP | claimed |
| US-20170081277-A1 | AMPHOTERIC COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2017-03-23 | — | — | US | claimed |
| WO-2017048528-A1 | AMPHOTERIC BETAINE COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2017-03-23 | — | — | WO | claimed |
| CN-118772021-A | Amphoteric betaine compounds | 伊士曼化工公司 | 2024-10-15 | — | — | CN | disclosed |
| US-11414380-B2 | Amphoteric compounds | EASTMAN CHEMICAL COMPANY (US) | 2022-08-16 | — | — | US | disclosed |
| EP-3350160-B1 | MIXTURES OF AMPHOTERIC BETAINE COMPOUNDS AND AN ENZYMIC PROCESS FOR THEIR PRODUCTION | EASTMAN CHEM CO (US) | 2021-05-26 | — | — | EP | disclosed |
| EP-3350160-A1 | AMPHOTERIC BETAINE COMPOUNDS | Eastman Chemical Company (US) | 2018-07-25 | — | — | EP | disclosed |
| US-20170081277-A1 | AMPHOTERIC COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2017-03-23 | — | — | US | disclosed |
| WO-2017048528-A1 | AMPHOTERIC BETAINE COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2017-03-23 | — | — | WO | disclosed |
| EP-1951315-A2 | PHOSPHOLIPASE INHIBITORS, INCLUDING MULTI-VALENT PHOSPHOLIPASE INHIBITORS, AND USE THEREOF, INCLUDING AS LUMEN-LOCALIZED PHOSPHOLIPASE INHIBITORS | Ilypsa, Inc. (US) | 2008-08-06 | — | — | EP | disclosed |
| US-20070135383-A1 | Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors | ILYPSA, INC. | 2007-06-14 | — | — | US | disclosed |
| WO-2007056279-A2 | PHOSPHOLIPASE INHIBITORS, INCLUDING MULTI-VALENT PHOSPHOLIPASE INHIBITORS, AND USE THEREOF, INCLUDING AS LUMEN-LOCALIZED PHOSPHOLIPASE INHIBITORS | ILYPSA, INC. (US) | 2007-05-18 | — | — | WO | disclosed |